Novartis to Buy MorphoSys for $2.9 Billion; Deal Seen Closing in 1H Novartis said the acquisition expands and complements its pipeline in oncology.
Virgin Galactic Reports Flight Issue to.
UBS to Restart Buybacks This Year UBS said it will resume share buybacks in 2024 after it reported a net loss for the fourth quarter that was slightly better than forecast.
BP Beats.
Novartis to Buy MorphoSys for $2.9 Billion; Deal Seen Closing in 1H Novartis said the acquisition expands and complements its pipeline in oncology.
Virgin Galactic Reports Flight Issue to.
Novartis to Buy MorphoSys for $2.9 Billion; Deal Seen Closing in 1H Novartis said the acquisition expands and complements its pipeline in oncology.
Virgin Galactic Reports Flight Issue to.